Brookdale Senior Living Inc (NYSE: BKD) stock jumped 5.52% on Monday to $5.54 against a previous-day closing price of $5.25. With 4.2 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.37 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $5.58 whereas the lowest price it dropped to was $5.24. The 52-week range on BKD shows that it touched its highest point at $5.30 and its lowest point at $2.27 during that stretch. It currently has a 1-year price target of $5.65. Beta for the stock currently stands at 1.37.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BKD was up-trending over the past week, with a rise of 35.45%, but this was up by 46.56% over a month. Three-month performance surged to 33.17% while six-month performance rose 49.73%. The stock gained 78.14% in the past year, while it has gained 102.93% so far this year. A look at the trailing 12-month EPS for BKD yields -0.56 with Next year EPS estimates of -0.65. For the next quarter, that number is -0.21. This implies an EPS growth rate of 48.00% for this year and 0.77% for next year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 16.42%.
Float and Shares Shorts:
At present, 187.25 million BKD shares are outstanding with a float of 168.91 million shares on hand for trading. In addition to Ms. Lucinda M. Baier as the firm’s President, CEO & Director, Ms. Dawn L. Kussow serves as its Executive VP & CFO.
Through their ownership of 105.10% of BKD’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 59.04% of BKD, in contrast to 40.81% held by mutual funds. Shares owned by individuals account for 30.63%. As the largest shareholder in BKD with 9.91% of the stake, Glenview Capital Management LLC holds 18,644,673 shares worth 18,644,673. A second-largest stockholder of BKD, Camber Capital Management LP, holds 18,000,000 shares, controlling over 9.56% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in BKD, holding 17,604,009 shares or 9.35% stake. With a 3.54% stake in BKD, the BlackRock Event Driven Equity Fun is the largest stakeholder. A total of 6,666,565 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.98% of BKD stock, is the second-largest Mutual Fund holder. It holds 5,604,636 shares valued at 21.91 million. Vanguard Small Cap Index Fund holds 2.44% of the stake in BKD, owning 4,595,216 shares worth 17.97 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BKD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BKD analysts setting a high price target of $9.00 and a low target of $3.95, the average target price over the next 12 months is $5.65. Based on these targets, BKD could surge 62.45% to reach the target high and fall by -28.7% to reach the target low. Reaching the average price target will result in a growth of 1.99% from current levels.
Summary of Insider Activity:
Insiders traded BKD stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 6,944 shares were bought while 0 shares were sold. The number of buy transactions has increased to 26 while that of sell transactions has risen to 16 over the past year. The total number of shares bought during that period was 1,879,324 while 616,194 shares were sold.